Skip to main content
Premium Trial:

Request an Annual Quote

Rolf Muller

BioFluidica has appointed Rolf Muller as CEO. He will assume responsibilities immediately and will succeed Steven Soper, who will remain the company’s chief technology officer. BioFluidica develops technologies for the isolation and analysis of rare, circulating biomarkers in the blood. The company's first platform is being used analyze liquid biopsies to isolate circulating tumor cells and other rare cells from the blood. Prior to joining BioFluidica, Muller was the cofounder and president of Biomatrica. 

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.